Profiles: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 2]]: Consensus (Publicly Reviewed)=== | ===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 2]]: Consensus (Publicly Reviewed)=== | ||
* | * [[Media:QIBA_CVol_TumorVolumeChangeProfile_Consensus-20161121.pdf| CT Tumor Volumetry for Advanced Disease 2016-11-21]] | ||
===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 1]]: Public Comment=== | ===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 1]]: Public Comment=== | ||
* [[Media:DCEMRIProfile v1 6-20111213.pdf|DCE-MRI Quantification 2011-12-13]] (''Public Comment ended Feb 2012'') | * [[Media:DCEMRIProfile v1 6-20111213.pdf|DCE-MRI Quantification 2011-12-13]] (''Public Comment ended Feb 2012'') | ||
Revision as of 18:51, 21 November 2016
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed
Stage 2: Consensus (Publicly Reviewed)
Stage 1: Public Comment
- DCE-MRI Quantification 2011-12-13 (Public Comment ended Feb 2012)
See Also
- How to use QIBA Profiles
- QIBA Profile Template shows the structure, rationale and content of a Profile (show All Markup to see guidance in the Word comments)
- Committees lists Biomarker Committees developing profiles which may link to DRAFT documents in progress for the next stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.